牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

恩威医药（301331）

4.5

综合诊断：4.5分打败了53%的股票！

卖出
减持
中性
增持
买入

短期趋势：
市场最近连续上涨中，短期小心回调。
中期趋势：
-
长期趋势：
已有22家主力机构披露2024-12-31报告期持股数据，持仓量总计451.41万股，占流通A股13.64%
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

4.7分

2.2分

5.6分

3.5分

5.9分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：4.7技术面打败了94%的股票技术面评分前10的股票

近期的平均成本为33.13元。

技术面得分最高的股票

平均成本

近期的平均成本为33.13元。

[{"text":"\u5e73\u5747\u6210\u672c","value":"33.13","date":1751530910,"color":"0x9f0ba1"}]

市场表现

过去10个交易日，该股走势跑赢大盘，跑赢行业平均水平。

[{"date":"2025.07.04","stock":"1.74","trade":"-0.36","ind":"-0.25"},{"date":"2025.07.03","stock":"1.30","trade":"1.72","ind":"1.17"},{"date":"2025.07.02","stock":"-1.64","trade":"-0.30","ind":"-0.61"},{"date":"2025.07.01","stock":"4.25","trade":"1.61","ind":"0.11"},{"date":"2025.06.30","stock":"-0.03","trade":"0.30","ind":"0.83"},{"date":"2025.06.27","stock":"3.99","trade":"0.38","ind":"0.34"},{"date":"2025.06.26","stock":"2.71","trade":"-0.51","ind":"-0.48"},{"date":"2025.06.25","stock":"-0.67","trade":"0.24","ind":"1.72"},{"date":"2025.06.24","stock":"0.00","trade":"1.40","ind":"1.68"},{"date":"2025.06.23","stock":"0.68","trade":"0.71","ind":"0.43"},{"date":"2025.06.20","stock":"2.47","trade":"-0.05","ind":"-0.47"},{"date":"2025.06.19","stock":"-4.13","trade":"-1.61","ind":"-1.21"},{"date":"2025.06.18","stock":"-0.89","trade":"-1.39","ind":"0.24"},{"date":"2025.06.17","stock":"-4.90","trade":"-0.79","ind":"-0.12"},{"date":"2025.06.16","stock":"-2.12","trade":"-0.34","ind":"0.41"},{"date":"2025.06.13","stock":"3.73","trade":"-2.44","ind":"-1.10"},{"date":"2025.06.12","stock":"-1.23","trade":"0.26","ind":"-0.11"},{"date":"2025.06.11","stock":"1.11","trade":"0.22","ind":"0.83"},{"date":"2025.06.10","stock":"12.01","trade":"0.01","ind":"-0.86"},{"date":"2025.06.09","stock":"2.33","trade":"2.07","ind":"0.65"},{"date":"2025.06.06","stock":"1.44","trade":"0.04","ind":"-0.19"}]

恩威医药,深证成指,中药指数

压力支撑

该股压力位为33.01元，支撑位为32.22元。

[{"text":"\u538b\u529b\u4f4d","value":"33.01","date":1751558400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"32.22","date":1751558400,"color":"0x0b52a1"}]

多空趋势

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：2.2资金面打败了12%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金总体无进出。

更新时间：07月04日 20:30

机构今日流向(万元)	-442.59	机构5日流向(万元)	-621.39
机构10日流向(万元)	-3117.34	机构20日流向(万元)	-17830.65

机构持仓

2024-12-31 与 2024-06-30 相比，主力机构持仓量减少391.35万股，其中基金净减仓1家，主力净增仓1家，暂未发现中长期投资价值。

截止2024-12-31，共22家主力机构（基金16家，一般法人6家），持仓量总计451.41万股，占流通A股13.64%
其中，基金持仓与2024-06-30相比：
增仓：0家，增持 0万股
减仓：1家，减持 0.01万股
新出现在主力名单中：14家，持有91.88万股
从主力名单中消失：13家，原持有337.15万股

消息面诊股

诊断结果：5.6消息面打败了43%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	重大事项	公司股东股份解押	2025-06-23
一般消息	重大事项	公司股东股份解押	2025-06-03
一般消息	重大事项	公司股东股份解押	2025-05-17
一般消息	高管变动	修订章程取消监事会	2025-05-12
一般消息	股东大会	年度股东大会	2025-04-21
利好	分红转增	10派1.8元(含税)	2025-04-21
一般消息	募资投向		2025-04-21
一般消息	重大事项	关联交易	2025-04-21
重大利空	业绩预告	业绩大幅下降	2025-01-17
一般消息	重大事项	公司股东股份解押	2024-12-30
一般消息	重大事项	公司股东股份解押	2024-11-15
一般消息	分红转增	不分配不转增	2024-08-30
一般消息	重大事项	公司股东股份解押	2024-08-16

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	1条	1条	0条

行业面诊股

诊断结果：3.5行业面打败了35%的股票中药行业最新资金流向

近10日来该行业走势明显向上，接近大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势明显向上，接近大盘。

[{"date":"2025.07.04","price":"-0.25","value":"-0.36"},{"date":"2025.07.03","price":"1.17","value":"1.72"},{"date":"2025.07.02","price":"-0.61","value":"-0.30"},{"date":"2025.07.01","price":"0.11","value":"1.61"},{"date":"2025.06.30","price":"0.83","value":"0.30"},{"date":"2025.06.27","price":"0.34","value":"0.38"},{"date":"2025.06.26","price":"-0.48","value":"-0.51"},{"date":"2025.06.25","price":"1.72","value":"0.24"},{"date":"2025.06.24","price":"1.68","value":"1.40"},{"date":"2025.06.23","price":"0.43","value":"0.71"},{"date":"2025.06.20","price":"-0.47","value":"-0.05"},{"date":"2025.06.19","price":"-1.21","value":"-1.61"},{"date":"2025.06.18","price":"0.24","value":"-1.39"},{"date":"2025.06.17","price":"-0.12","value":"-0.79"},{"date":"2025.06.16","price":"0.41","value":"-0.34"},{"date":"2025.06.13","price":"-1.10","value":"-2.44"},{"date":"2025.06.12","price":"-0.11","value":"0.26"},{"date":"2025.06.11","price":"0.83","value":"0.22"},{"date":"2025.06.10","price":"-0.86","value":"0.01"},{"date":"2025.06.09","price":"0.65","value":"2.07"},{"date":"2025.06.06","price":"-0.19","value":"0.04"}]

深证成指,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	方盛制药	154.43%	5.52%	5.7分
2	贵州百灵	39.37%	10.96%	4.8分
3	恩威医药	21.45%	5.65%	4.5分
4	启迪药业	18.13%	11.81%	4.9分
5	康惠制药	16.79%	12.52%	4.7分
6	众生药业	15.95%	8.10%	5.1分
7	康缘药业	14.80%	6.32%	5.0分
8	佐力药业	11.32%	12.64%	5.7分
9	珍宝岛	6.04%	0.51%	4.1分
10	九芝堂	5.79%	14.41%	5.6分
11	太极集团	5.08%	3.25%	5.1分
12	汉森制药	4.85%	4.34%	4.7分
13	-	4.39%	4.39%	分
14	红日药业	3.93%	7.59%	4.9分
15	*ST长药	3.67%	4.63%	4.3分
16	以岭药业	3.66%	6.99%	5.5分
17	吉林敖东	3.57%	0.23%	4.9分
18	新天药业	3.20%	4.65%	4.6分
19	济川药业	2.97%	-3.12%	4.3分
20	莱茵生物	2.65%	4.50%	5.2分
21	康恩贝	2.52%	2.05%	4.9分
22	益佰制药	2.28%	4.95%	5.1分
23	沃华医药	1.85%	6.87%	5.4分
24	粤万年青	1.73%	5.19%	4.7分
25	中恒集团	1.56%	3.57%	4.8分
26	羚锐制药	1.51%	3.66%	5.2分
27	太龙药业	1.21%	4.47%	5.2分
28	ST香雪	1.09%	-1.30%	4.2分
29	贵州三力	0.93%	3.47%	4.8分
30	益盛药业	0.50%	3.37%	4.8分
31	上海凯宝	0.48%	2.98%	5.0分
32	葵花药业	0.45%	1.02%	3.8分
33	华神科技	0.25%	2.86%	4.7分
34	新光药业	0.20%	3.56%	4.7分
35	亚宝药业	0.16%	3.30%	5.3分
36	仁和药业	0.00%	1.48%	4.6分
37	信邦制药	0.00%	2.31%	5.0分
38	白云山	-0.30%	0.65%	4.9分
39	千金药业	-0.93%	2.02%	5.3分
40	天目药业	-0.95%	-0.29%	5.4分
41	维康药业	-0.96%	2.29%	4.7分
42	嘉应制药	-1.09%	3.94%	4.9分
43	特一药业	-1.25%	2.96%	4.9分
44	云南白药	-1.43%	-0.16%	5.5分
45	金花股份	-1.92%	2.28%	4.6分
46	片仔癀	-2.19%	-1.06%	4.5分
47	达仁堂	-2.26%	1.22%	4.8分
48	天士力	-2.27%	1.59%	5.1分
49	康美药业	-2.56%	0.00%	4.3分
50	陇神戎发	-2.73%	3.74%	5.1分
51	同仁堂	-2.78%	-1.03%	4.6分
52	桂林三金	-3.70%	1.32%	5.5分
53	精华制药	-3.79%	2.65%	5.2分
54	健民集团	-4.10%	-0.48%	4.5分
55	佛慈制药	-4.33%	2.94%	4.8分
56	寿仙谷	-4.62%	-0.19%	3.7分
57	华润三九	-5.05%	-1.65%	4.9分
58	ST葫芦娃	-5.32%	0.11%	4.5分
59	马应龙	-5.85%	-3.32%	4.4分
60	东阿阿胶	-6.86%	-2.66%	4.6分
61	华森制药	-7.36%	1.76%	4.8分
62	昆药集团	-7.37%	0.00%	4.1分
63	奇正藏药	-7.50%	1.11%	4.5分
64	-	-21.92%	-3.26%	分
65	步长制药	-59.34%	2.34%	4.7分
66	广誉远	-	0.00%	5.8分
67	江中药业	-	0.73%	5.0分
68	盘龙药业	-	3.78%	4.9分
69	万邦德	-	4.39%	4.9分

<上一页 1 2 3 4 5...12 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：5.9基本面打败了49%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：强（100分）

基本面得分最高的股票

[ 截止日期：2025-03-31 ]公司经营

盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 44/112 ， 42/112。

[{"date":"2025-03-31","value":"1.53","vol":"2.23"},{"date":"2024-12-31","value":"3.47","vol":"5.32"},{"date":"2024-09-30","value":"2.07","vol":"2.95"},{"date":"2024-06-30","value":"1.69","vol":"1.60"},{"date":"2024-03-31","value":"0.77","vol":"1.67"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
净资产收益率(%)	1.53	3.47	2.07	1.69	0.77
行业(%)	2.23	5.32	2.95	1.60	1.67

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"48.13","vol":"53.01"},{"date":"2024-12-31","value":"50.82","vol":"52.47"},{"date":"2024-09-30","value":"50.95","vol":"52.77"},{"date":"2024-06-30","value":"51.87","vol":"53.17"},{"date":"2024-03-31","value":"50.26","vol":"53.62"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
销售毛利率(%)	48.13	50.82	50.95	51.87	50.26
行业(%)	53.01	52.47	52.77	53.17	53.62

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 15/112 ， 7/112。

[{"date":"2025-03-31","value":"7.10","vol":"-5.22"},{"date":"2024-12-31","value":"3.43","vol":"-6.80"},{"date":"2024-09-30","value":"-1.67","vol":"-4.36"},{"date":"2024-06-30","value":"-1.80","vol":"-4.12"},{"date":"2024-03-31","value":"-8.63","vol":"-2.27"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
营业收入同比增长率(%)	7.10	3.43	-1.67	-1.80	-8.63
行业(%)	-5.22	-6.80	-4.36	-4.12	-2.27

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"93.56","vol":"-35.55"},{"date":"2024-12-31","value":"-56.56","vol":"-101.25"},{"date":"2024-09-30","value":"-69.81","vol":"-6.00"},{"date":"2024-06-30","value":"-71.96","vol":"-15.66"},{"date":"2024-03-31","value":"-69.56","vol":"-9.41"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
净利润同比增长率(%)	93.56	-56.56	-69.81	-71.96	-69.56
行业(%)	-35.55	-101.25	-6.00	-15.66	-9.41

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 32/112 ， 13/112。

[{"date":"2025-03-31","value":"0.13","vol":"0.12"},{"date":"2024-12-31","value":"0.57","vol":"0.49"},{"date":"2024-09-30","value":"0.41","vol":"0.37"},{"date":"2024-06-30","value":"0.28","vol":"0.26"},{"date":"2024-03-31","value":"0.14","vol":"0.13"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
总资产周转率(次)	0.13	0.57	0.41	0.28	0.14
行业(次)	0.12	0.49	0.37	0.26	0.13

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"0.88","vol":"0.62"},{"date":"2024-12-31","value":"3.58","vol":"2.41"},{"date":"2024-09-30","value":"2.56","vol":"1.80"},{"date":"2024-06-30","value":"1.59","vol":"1.24"},{"date":"2024-03-31","value":"0.78","vol":"0.66"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
存货增长率(次)	0.88	3.58	2.56	1.59	0.78
行业(次)	0.62	2.41	1.80	1.24	0.66

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-03-31","value":"12.56","vol":"2.34"},{"date":"2024-12-31","value":"2.96","vol":"15.76"},{"date":"2024-09-30","value":"-10.92","vol":"6.40"},{"date":"2024-06-30","value":"41.14","vol":"11.96"},{"date":"2024-03-31","value":"3.31","vol":"1.49"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
现金流量净额/营业收入	12.56	2.96	-10.92	41.14	3.31
行业	2.34	15.76	6.40	11.96	1.49

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.95","vol":"1.45"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"1.12","vol":"1.38"},{"date":"2024-03-31","value":"","vol":"0.00"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
资本支出／折旧和摊销	-	0.95	-	1.12	-
行业	0.00	1.45	0.00	1.38	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 55/112 ， 57/112。

[{"date":"2025-03-31","value":"4.43","vol":"2.97"},{"date":"2024-12-31","value":"3.99","vol":"2.87"},{"date":"2024-09-30","value":"4.86","vol":"3.19"},{"date":"2024-06-30","value":"4.27","vol":"2.92"},{"date":"2024-03-31","value":"3.63","vol":"2.96"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
流动比率	4.43	3.99	4.86	4.27	3.63
行业	2.97	2.87	3.19	2.92	2.96

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"3.75","vol":"2.19"},{"date":"2024-12-31","value":"3.42","vol":"2.09"},{"date":"2024-09-30","value":"4.09","vol":"2.38"},{"date":"2024-06-30","value":"3.60","vol":"2.20"},{"date":"2024-03-31","value":"2.98","vol":"2.26"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
速动比率	3.75	3.42	4.09	3.60	2.98
行业	2.19	2.09	2.38	2.20	2.26

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 32/112 ， 35/112。

[{"date":"2025-03-31","value":"28.05","vol":"33.51"},{"date":"2024-12-31","value":"29.70","vol":"34.19"},{"date":"2024-09-30","value":"28.18","vol":"33.21"},{"date":"2024-06-30","value":"31.11","vol":"34.04"},{"date":"2024-03-31","value":"20.36","vol":"33.28"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
资产负债率(%)	28.05	29.70	28.18	31.11	20.36
行业(%)	33.51	34.19	33.21	34.04	33.28

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"0.39","vol":"0.73"},{"date":"2024-12-31","value":"0.42","vol":"0.75"},{"date":"2024-09-30","value":"0.39","vol":"3.21"},{"date":"2024-06-30","value":"0.45","vol":"1.65"},{"date":"2024-03-31","value":"0.26","vol":"0.98"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
产权比率 (%)	0.39	0.42	0.39	0.45	0.26
行业(%)	0.73	0.75	3.21	1.65	0.98

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2025年的收益，请投资者后续关注。

[{"date":"2021","yellowRectValue":"1.02","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.68","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.86","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.37","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[恩威医药]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]